Agnieszka Urbanek-Dadela
Overview
Explore the profile of Agnieszka Urbanek-Dadela including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
40
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sekowska A, Czyzewski K, Jaremek K, Zalas-Wiecek P, Zajac-Spychala O, Wachowiak J, et al.
J Clin Med
. 2024 Jul;
13(14).
PMID: 39064118
is a nosocomial pathogen that causes severe infections in immunocompromised patients. The aim of the study was to conduct a microbiological and clinical analysis of infections in children with malignancies...
2.
Zawitkowska J, Drabko K, Lejman M, Kowalczyk A, Czyzewski K, Dziedzic M, et al.
Sci Rep
. 2023 Dec;
13(1):22619.
PMID: 38114744
The most common complications related to the treatment of childhood acute lymphoblastic leukemia (ALL) are infections. The aim of the study was to analyze the incidence and mortality rates among...
3.
Zawitkowska J, Drabko K, Czyzewski K, Dziedzic M, Jaremek K, Zalas-Wiecek P, et al.
Pathogens
. 2022 Oct;
11(10).
PMID: 36297147
Viral infections can be a serious complication of therapy in children with acute lymphoblastic leukemia (ALL). In this study, we focused on the incidence and the profile of viral infection...
4.
Richert-Przygonska M, Czyzewski K, Dziedzic M, Zalas-Wiecek P, Gryniewicz-Kwiatkowska O, Gietka A, et al.
Pediatr Infect Dis J
. 2022 Jul;
41(10):846-850.
PMID: 35797710
Background: Infections caused by Stenotrophomonas maltophilia (SM) have documented high mortality rate in immunocompromised patients. Aim: This nationwide multicenter study was performed to analyze the epidemiology of SM infections in...
5.
Zajac-Spychala O, Wachowiak J, Gryniewicz-Kwiatkowska O, Gietka A, Dembowska-Baginska B, Semczuk K, et al.
Microb Drug Resist
. 2020 May;
27(1):53-63.
PMID: 32434455
Infectious complications (IC) caused by bacterial strains often impede anticancer therapy. The study aimed to retrospectively analyze bacterial IC that could help predict the risk and optimize the empirical treatment...
6.
Zawitkowska J, Lejman M, Szmydki-Baran A, Zaucha-Prazmo A, Czyzewski K, Dziedzic M, et al.
J Med Virol
. 2020 May;
92(12):3645-3649.
PMID: 32406935
Varicella-zoster virus (VZV) infection in pediatric hemato-oncology patients can be a therapeutic problem when children are exposed to immunosuppression. The aim of this study is to evaluate the incidence of...
7.
Czyzewski K, Galazka P, Fraczkiewicz J, Salamonowicz M, Szmydki-Baran A, Zajac-Spychala O, et al.
Mycoses
. 2019 Aug;
62(11):990-998.
PMID: 31429997
The objective of the study was the analysis of incidence and outcome of invasive fungal disease (IFD) in children treated for malignancy (PHO, paediatric hematology-oncology) or undergoing hematopoietic cell transplantation...
8.
Zajac-Spychala O, Skalska-Sadowska J, Wachowiak J, Szmydki-Baran A, Hutnik L, Matysiak M, et al.
Leuk Lymphoma
. 2019 May;
60(12):3028-3035.
PMID: 31132917
The aim of this nationwide study was to describe the epidemiology and profile of bacterial infections (BI), invasive fungal disease (IFD) and viral infections (VI) in patients with and relapsed/refractory...
9.
Zawitkowska J, Drabko K, Szmydki-Baran A, Zaucha-Prazmo A, Lejman M, Czyzewski K, et al.
J Infect Chemother
. 2019 May;
25(10):774-779.
PMID: 31101529
Introduction: The treatment-related mortality in currently published studies of acute lymphoblastic leukemia (ALL) in children is 2-4%, mainly due to infections. The aim of the study was to analyse the...
10.
Zajac-Spychala O, Wachowiak J, Szmydki-Baran A, Hutnik L, Salamonowicz M, Matysiak M, et al.
Leuk Lymphoma
. 2018 Nov;
60(1):124-132.
PMID: 30392426
The objective of this nation-wide study was to evaluate the epidemiology and profile of bacterial (BI), viral (VI), and invasive fungal disease (IFD) in patients treated for non-Hodgkin lymphoma (NHL)...